Skip to content
★ Sign in to follow
KL

Keith Lamont Cummings

CFO
Chief Financial Officer
Pliant Therapeutics, Inc.
Insider activity · 24 months0 buys2 salesCumulative net flow
Total declarations
19
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€1.1M

Latest filing published 22 Jan 2026 for Pliant Therapeutics, INC., €26k.

Filing timeline

BuySale
Keith Lamont Cummings

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Keith Lamont Cummings: trading record in brief

All filings by Keith Lamont Cummings on record concern Pliant Therapeutics, Inc., in the capacity of finance chief. We count 19 filings; the first trade dates from 3 September 2021 and the latest from 20 January 2026.

No open-market purchase appears, only 6 sales worth €1.1M. The rest of the record consists of 7 share grants and 6 option exercises. Since January 2026: no purchases and 1 sale on the market.

Most recently, on 22 January 2026, the filings show an open-market sale worth €26k in Pliant Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Keith Lamont Cummings

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total

19 of 19 declarations